Table 1 Baseline characteristics of the study population.
Total (N = 1502) | |
---|---|
Age, years | 54 (45–63) |
Male, n (%) | 921 (61.3) |
Body mass index, kg/m2 | 24.4 (22.3–26.4)* |
Hemoglobin, g/dL | 13 (11.6–14.5) |
BUN, mg/dL | 18 (14–25) |
Creatinine, mg/dL | 1.4 (1.0–2.0) |
eGFRcreatinine, mL/min/1.73 m2 | 46.7 (30.5–70.8) |
Sodium, mEq/L | 141 (140–142) |
Potassium, mEq/L | 4.5 (4.2–4.9) |
Calcium, mg/dL | 9.5 (9.1–9.8) |
Phosphorus, mg/dL | 3.6 (3.2–4.0) |
Uric acid, mg/dL | 6.9 (5.6–8.1) |
Parathyroid hormone, pg/dL | 49.25 (33.6–75.1) |
CRP, mg/dL | 0.6 (0.2–1.6) |
Fasting glucose, mg/dL | 99 (92–111) |
HbA1C, % | 6.3 (5.6–7.4) |
Total cholesterol, mg/dL | 172 (147–198) |
HDL-C, mg/dL | 47 (39–59) |
LDL-C, mg/dL | 94 (74–115) |
FGF-23, pg/mL | 18.2 (1.3–31.9) |
Spot urine protein-to-creatinine ratio, mg/mg | 1.12 (0.01–16.75) |
Systolic blood pressure, mmHg | 126 (118–135)* |
Diastolic blood pressure, mmHg | 77 (70–84) |
Comorbidities | |
Hypertension, n (%) | 1435 (95.5) |
Diabetes mellitus, n (%) | 466 (31.0) |
Coronary artery disease, n (%) | 94 (6.3) |
Chronic heart failure, n (%) | 18 (1.2) |
Smoking status, n (%) | |
Current | 240 (16.0) |
Former | 471 (31.4) |
Never | 791 (52.6) |
CKD subtype, n (%) | |
Diabetes mellitus | 356 (23.7) |
Hypertension | 287 (19.1) |
Glomerulonephritis | 570 (38.0) |
Polycystic kidney disease | 289 (19.2) |